IO Biotech, Inc.·4

Aug 9, 8:38 PM ET

Smith Devin Whittemore 4

4 · IO Biotech, Inc. · Filed Aug 9, 2023

Insider Transaction Report

Form 4
Period: 2023-08-09
Smith Devin Whittemore
General Counsel
Transactions
  • Award

    Warrants (Right to Buy)

    2023-08-09$0.13/sh+4,938$6174,938 total
    Exercise: $2.47From: 2023-08-09Common Stock (4,938 underlying)
  • Award

    Common Stock

    2023-08-09$1.90/sh+4,938$9,3824,938 total
Footnotes (1)
  • [F1]These Warrants expire at 5:00 p.m. Eastern time on the earlier of (i) February 9, 2027, and (ii) one day prior to the closing of an Acquisition of the Issuer, as defined in the Form of Warrant, attached as Exhibit 4.1 to the Issuer's Current Report on Form 8-K, filed with the Securities and Exchange Commission on August 7, 2023.

Documents

1 file
  • 4
    form4.xmlPrimary